Samuel Navarro
About
Samuel Navarro is a scholar working on Neurology, Pulmonary and Respiratory Medicine and Oncology.
According to data from OpenAlex, Samuel Navarro has authored 154 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Neurology, 61 papers in Pulmonary and Respiratory Medicine and 42 papers in Oncology. Recurrent topics in Samuel Navarro's work include Neuroblastoma Research and Treatments (57 papers), Sarcoma Diagnosis and Treatment (52 papers) and Cancer, Hypoxia, and Metabolism (24 papers). Samuel Navarro is often cited by papers focused on Neuroblastoma Research and Treatments (57 papers), Sarcoma Diagnosis and Treatment (52 papers) and Cancer, Hypoxia, and Metabolism (24 papers). Samuel Navarro collaborates with scholars based in Spain, Italy and United States. Samuel Navarro's co-authors include Rosa Noguera, Antonio Llombart‐Bosch, Isidro Machado, Sven Påhlman, Erik Fredlund, Alexander Pietras, Tobias Löfstedt, Linda Holmquist Mengelbier, Adela Cañete and Helén Nilsson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.
In The Last Decade
Samuel Navarro
146 papers receiving 3.8k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Samuel Navarro Spain | 34 | 1.3k | 1.2k | 1.1k | 1.1k | 825 | 154 | 3.8k | ||
| Barbara Dockhorn‐Dworniczak Germany | 39 | 1.9k 1.5× | 1.8k 1.5× | 1.0k 0.9× | 1.4k 1.3× | 609 0.7× | 112 | 5.0k | ||
| Svetlana Pack United States | 47 | 3.1k 2.5× | 1.4k 1.1× | 1.1k 0.9× | 1.5k 1.5× | 578 0.7× | 130 | 6.5k | ||
| Maria Cristina Manara Italy | 45 | 2.9k 2.3× | 2.4k 1.9× | 1.3k 1.1× | 1.6k 1.5× | 351 0.4× | 117 | 5.5k | ||
| David Gisselsson Sweden | 40 | 2.7k 2.1× | 1.0k 0.9× | 1.4k 1.2× | 1.1k 1.1× | 491 0.6× | 151 | 5.0k | ||
| Janusz Limon Poland | 40 | 1.8k 1.5× | 2.6k 2.1× | 968 0.9× | 1.2k 1.1× | 391 0.5× | 240 | 5.8k | ||
| Stephen X. Skapek United States | 35 | 3.0k 2.4× | 1.9k 1.5× | 745 0.7× | 1.8k 1.7× | 376 0.5× | 97 | 5.5k | ||
| Arupa Ganguly United States | 48 | 2.5k 2.0× | 642 0.5× | 724 0.6× | 1.3k 1.2× | 356 0.4× | 144 | 6.5k | ||
| Dolores López‐Terrada United States | 35 | 1.5k 1.2× | 2.5k 2.0× | 661 0.6× | 1.7k 1.6× | 462 0.6× | 142 | 5.3k | ||
| David M. Loeb United States | 39 | 2.4k 1.9× | 1.3k 1.0× | 620 0.5× | 1.2k 1.1× | 266 0.3× | 142 | 4.6k | ||
| Sabrina Rossi Italy | 24 | 1.0k 0.8× | 1.0k 0.8× | 483 0.4× | 636 0.6× | 267 0.3× | 55 | 2.5k |
Countries citing papers authored by Samuel Navarro
Since
Specialization
Citations
This map shows the geographic impact of Samuel Navarro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel Navarro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel Navarro more than expected).
Fields of papers citing papers by Samuel Navarro
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Samuel Navarro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel Navarro. The network helps show where Samuel Navarro may publish in the future.
Co-authorship network of co-authors of Samuel Navarro
This figure shows the co-authorship network connecting the top 25 collaborators of Samuel Navarro. A scholar is included among the top collaborators of Samuel Navarro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samuel Navarro. Samuel Navarro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Jarzembowski, Jason A., Klaus Beiske, Susan L. Cohn, et al.. (2025). Data set for reporting of peripheral neuroblastic tumours: recommendations from the international collaboration on cancer reporting (ICCR ). Histopathology. 87(3). 343–356.
2.
Giner, Francisco, et al.. (2025). The Prognostic Impact of the Tumor Immune Microenvironment in Synovial Sarcoma: An Immunohistochemical Analysis Using Digital Pathology and Conventional Interpretation. Journal of Personalized Medicine. 15(5). 169–169.
3.
Westermann, Frank, et al.. (2024). Tackling ALT-positive neuroblastoma: is it time to redefine risk classification systems? A systematic review with IPD meta-analysis. Neoplasia. 60. 101106–101106.
4.
López-Carrasco, Amparo, Nuria Estáñ, Raquel Portugal, et al.. (2024). Vitronectin Levels in the Plasma of Neuroblastoma Patients and Culture Media of 3D Models: A Prognostic Circulating Biomarker?. International Journal of Molecular Sciences. 25(16). 8733–8733.
5.
Machado, Isidro, et al.. (2024). Immunological Tumor Microenvironment of Solitary Fibrous Tumors—Associating Immune Infiltrate with Variables of Prognostic Significance. Cancers. 16(18). 3222–3222.
6.
López-Carrasco, Amparo, et al.. (2024). Characterization of Vitronectin Effect in 3D Ewing Sarcoma Models: A Digital Microscopic Analysis of Two Cell Lines. Cancers. 16(19). 3347–3347.
7.
Giner, Francisco, Raquel López-Reig, Isidro Machado, et al.. (2024). The Combined Immunohistochemical Expression of GLI1 and BCOR in Synovial Sarcomas for the Identification of Three Risk Groups and Their Prognostic Outcomes: A Study of 52 Patients. International Journal of Molecular Sciences. 25(14). 7615–7615.
8.
Giner, Francisco, Isidro Machado, José Antonio López‐Guerrero, et al.. (2023). Intimal Sarcoma with MDM2/CDK4 Amplification and p16 Overexpression: A Review of Histological Features in Primary Tumor and Xenograft, with Immunophenotype and Molecular Profiling. International Journal of Molecular Sciences. 24(8). 7535–7535.
9.
Burgos‐Panadero, Rebeca, Inmaculada Noguera, Carlos Rodríguez‐Nogales, et al.. (2021). Unraveling the extracellular matrix-tumor cell interactions to aid better targeted therapies for neuroblastoma. International Journal of Pharmaceutics. 608. 121058–121058.
10.
Burgos‐Panadero, Rebeca, et al.. (2020). Digital Image Analysis Applied to Tumor Cell Proliferation, Aggressiveness, and Migration-Related Protein Synthesis in Neuroblastoma 3D Models. International Journal of Molecular Sciences. 21(22). 8676–8676.
11.
Carretero, Aitor, et al.. (2020). A three-dimensional bioprinted model to evaluate the effect of stiffness on neuroblastoma cell cluster dynamics and behavior. Scientific Reports. 10(1). 6370–6370.
12.
Boscá-Watts, Marta Maia, Miguel Mínguez, Dolores Planelles, et al.. (2018). HLA-DQ: Celiac diseasevsinflammatory bowel disease. World Journal of Gastroenterology. 24(1). 96–103.
13.
Tadeo, Irene, Marta Piqueras, David Montaner, et al.. (2013). Quantitative modeling of clinical, cellular, and extracellular matrix variables suggest prognostic indicators in cancer: a model in neuroblastoma. Pediatric Research. 75(2). 302–314.
14.
Øra, Ingrid, Attila Frigyesi, Victoria Castel, et al.. (2011). Alternative lengthening of telomeres—An enhanced chromosomal instability in aggressive non‐MYCN amplified and telomere elongated neuroblastomas. Genes Chromosomes and Cancer. 50(4). 250–262.
15.
Roda, Desamparados, Matteo Frasson, Susana Roselló, et al.. (2010). The role of the pathologist in rectal cancer diagnosis and staging and surgical quality assessment. Clinical & Translational Oncology. 12(5). 339–345.
16.
Noguera, Rosa, Erik Fredlund, Marta Piqueras, et al.. (2009). HIF-1α and HIF-2α Are Differentially Regulated In vivo in Neuroblastoma: High HIF-1α Correlates Negatively to Advanced Clinical Stage and Tumor Vascularization. Clinical Cancer Research. 15(23). 7130–7136.
17.
Pietras, Alexander, Loen M. Hansford, A. Johnsson, et al.. (2009). HIF-2α maintains an undifferentiated state in neural crest-like human neuroblastoma tumor-initiating cells. Proceedings of the National Academy of Sciences. 106(39). 16805–16810.
18.
Löfstedt, Tobias, Erik Fredlund, Rosa Noguera, et al.. (2009). HIF-1α induces MXI1 by alternate promoter usage in human neuroblastoma cells. Experimental Cell Research. 315(11). 1924–1936.
19.
Navarro, Samuel, et al.. (2005). Mutational Analysis of the c-KIT AND PDGFR?? in a Series of Molecularly Well-Characterized Synovial Sarcomas. Diagnostic Molecular Pathology. 14(3). 134–139.
20.
López‐Guerrero, José Antonio, Samuel Navarro, Rosa Noguera, et al.. (2003). Histological tumor grade correlates with HER2/c-erB-2 status in invasive breast cancer: a comparative analysis between immunohistochemical (CB11 clone and Herceptest), FISH and differential PCR procedures.. PubMed. 65(1). 50–5.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Barbara Dockhorn‐Dworniczak Breakdown of academic impact, for papers by Svetlana Pack Breakdown of academic impact, for papers by Maria Cristina Manara Breakdown of academic impact, for papers by David Gisselsson Breakdown of academic impact, for papers by Janusz Limon Breakdown of academic impact, for papers by Stephen X. Skapek Breakdown of academic impact, for papers by Arupa Ganguly Breakdown of academic impact, for papers by Dolores López‐Terrada Breakdown of academic impact, for papers by David M. Loeb Breakdown of academic impact, for papers by Sabrina Rossi